Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Dermatol ; 154(5): 880-4, 2006 May.
Article in English | MEDLINE | ID: mdl-16634890

ABSTRACT

BACKGROUND: Eruptive naevi have been described to potentially arise in immune compromised patients. OBJECTIVES: We describe three patients with eruptive benign melanocytic naevi during a phase of immunosuppressive therapy. METHODS/DIAGNOSIS: Two patients with Crohn disease were treated with either azathioprine monotherapy or a combination of azathioprine and infliximab, when eruptive naevi arose particularly at the palms and soles. Our third patient with plaque psoriasis developed eruptive naevi during two episodes of treatment: during a course with the biological agent alefacept and during etanercept therapy. CONCLUSIONS: We conclude that treatment with the recently available biological agents might be associated with the formation of eruptive naevi. Although positive evidence for the occurrence of malignant pigmented lesions is lacking, alertness to the development of eruptive melanocytic naevi during treatment with biological agents is indicated.


Subject(s)
Drug Eruptions/etiology , Immunologic Factors/adverse effects , Immunosuppressive Agents/adverse effects , Nevus, Pigmented/chemically induced , Skin Neoplasms/chemically induced , Adult , Azathioprine/adverse effects , Drug Eruptions/immunology , Drug Eruptions/pathology , Female , Humans , Immunocompromised Host , Male , Middle Aged , Nevus, Pigmented/immunology , Nevus, Pigmented/pathology , Skin Neoplasms/immunology , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...